To the Editor: Neurofibromatosis type 1(NF-1), or Von Recklinghausen disease, is a genetic disorder inherited in an autosomal dominant pattern. It is caused by a mutation in the neurofibromin gene located on chromosom...To the Editor: Neurofibromatosis type 1(NF-1), or Von Recklinghausen disease, is a genetic disorder inherited in an autosomal dominant pattern. It is caused by a mutation in the neurofibromin gene located on chromosome 17, accounting for 96% of all neurofibromatosis cases. This condition can affect multiple systems and often leads to the formation of tumors along the nervous system [1]. Patients with NF-1 may exhibit various symptoms, including Lisch nodules, neurofibromas, scoliosis, café au lait spots, learning disabilities, vision disorders, and epilepsy.展开更多
作为一种新型的治疗手段,纳秒脉冲电场(Nanosecond Pulse Electric Field,nsPEF)在黑色素瘤治疗中显示出了良好的应用前景。本文综述了nsPEF治疗黑色素瘤在细胞实验、动物实验与人体实验方面的研究进展,指出了nsPEF可通过多种机制诱导...作为一种新型的治疗手段,纳秒脉冲电场(Nanosecond Pulse Electric Field,nsPEF)在黑色素瘤治疗中显示出了良好的应用前景。本文综述了nsPEF治疗黑色素瘤在细胞实验、动物实验与人体实验方面的研究进展,指出了nsPEF可通过多种机制诱导黑色素瘤消融,并产生长期抗肿瘤记忆抑制其复发转移,同时具有高度靶向效果,不产生额外热损伤。这些独特优势对于黑色素瘤治疗具有广阔的临床应用前景,为临床治疗黑色素瘤提供了新的思路。展开更多
纳秒脉冲电场(Nanosecond Pulsed Electric Fields,nsPEF)是一种新兴的治疗技术,具有短脉冲宽度和高能量强度等特点。传统的高压脉冲电场已证实该项技术能够成功地应用于食品消毒保存、污水处理、生物育种及恶性肿瘤的电治疗等领域,具...纳秒脉冲电场(Nanosecond Pulsed Electric Fields,nsPEF)是一种新兴的治疗技术,具有短脉冲宽度和高能量强度等特点。传统的高压脉冲电场已证实该项技术能够成功地应用于食品消毒保存、污水处理、生物育种及恶性肿瘤的电治疗等领域,具有极大的开发价值与应用前景。现在针对nsPEF在恶性肿瘤物理治疗中的研究也已非常深入,但在肌骨运动系统还相对有所不足。本研究从nsPEF在骨折、肌腱/韧带疾患及肌肉损伤中入手,进一步总结nsPEF的重要意义与应用前景,并对未来相关的研究进行展望。展开更多
Acral melanoma(AM)is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate,largely due to the inconspicuous nature of early-stage le...Acral melanoma(AM)is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate,largely due to the inconspicuous nature of early-stage lesions,which can lead to late diagnosis.Because of the overlapping clinical and histopathological features of AM with other forms of cutaneous melanomas,early detection of AM requires a multidisciplinary approach that integrates various diagnostic modalities,including clinical examination,dermoscopy,histopathology,molecular testing,radiological imaging,and blood tests.While surgery is the preferred method of treatment for AM,other therapeutic options may be employed based on the stage and underlying etiology of the disease.Immune checkpoint inhibitors,molecular targeted therapy,radiotherapy,chemotherapy,and oncolytic virotherapy represent promising advanced treatment options for AM.In this review,we provide an overview of the latest advancements in diagnostic and therapeutic methods for AM,highlighting the importance of early detection and the prompt,individualized management of this challenging disease.展开更多
Prostate cancer is the second most common cancer in men,accounting for 14.1%of new cancer cases in 2020.The aggressiveness of prostate cancer is highly variable,depending on its grade and stage at the time of diagnosi...Prostate cancer is the second most common cancer in men,accounting for 14.1%of new cancer cases in 2020.The aggressiveness of prostate cancer is highly variable,depending on its grade and stage at the time of diagnosis.Despite recent advances in prostate cancer treatment,some patients still experience recurrence or even progression after undergoing radical treatment.Accurate initial staging and monitoring for recurrence determine patient management,which in turn affect patient prognosis and survival.Classical imaging has limitations in the diagnosis and treatment of prostate cancer,but the use of novel molecular probes has improved the detection rate,specificity,and accuracy of prostate cancer detection.Molecular probe-based imaging modalities allow the visualization and quantitative measurement of biological processes at the molecular and cellular levels in living systems.An increased understanding of tumor biology of prostate cancer and the discovery of new tumor biomarkers have allowed the exploration of additional molecular probe targets.The development of novel ligands and advances in nano-based delivery technologies have accelerated the research and development of molecular probes.Here,we summarize the use of molecular probes in positron emission tomography(PET),single-photon emission computed tomography(SPECT),magnetic resonance imaging(MRI),optical imaging,and ultrasound imaging,and provide a brief overview of important target molecules in prostate cancer.展开更多
基金supported by a grant from Zhejiang Provincial Natural Science Foundation (LS21H060001)。
文摘To the Editor: Neurofibromatosis type 1(NF-1), or Von Recklinghausen disease, is a genetic disorder inherited in an autosomal dominant pattern. It is caused by a mutation in the neurofibromin gene located on chromosome 17, accounting for 96% of all neurofibromatosis cases. This condition can affect multiple systems and often leads to the formation of tumors along the nervous system [1]. Patients with NF-1 may exhibit various symptoms, including Lisch nodules, neurofibromas, scoliosis, café au lait spots, learning disabilities, vision disorders, and epilepsy.
文摘作为一种新型的治疗手段,纳秒脉冲电场(Nanosecond Pulse Electric Field,nsPEF)在黑色素瘤治疗中显示出了良好的应用前景。本文综述了nsPEF治疗黑色素瘤在细胞实验、动物实验与人体实验方面的研究进展,指出了nsPEF可通过多种机制诱导黑色素瘤消融,并产生长期抗肿瘤记忆抑制其复发转移,同时具有高度靶向效果,不产生额外热损伤。这些独特优势对于黑色素瘤治疗具有广阔的临床应用前景,为临床治疗黑色素瘤提供了新的思路。
文摘纳秒脉冲电场(Nanosecond Pulsed Electric Fields,nsPEF)是一种新兴的治疗技术,具有短脉冲宽度和高能量强度等特点。传统的高压脉冲电场已证实该项技术能够成功地应用于食品消毒保存、污水处理、生物育种及恶性肿瘤的电治疗等领域,具有极大的开发价值与应用前景。现在针对nsPEF在恶性肿瘤物理治疗中的研究也已非常深入,但在肌骨运动系统还相对有所不足。本研究从nsPEF在骨折、肌腱/韧带疾患及肌肉损伤中入手,进一步总结nsPEF的重要意义与应用前景,并对未来相关的研究进行展望。
基金This work was supported by the Zhejiang Provincial Natural Science Foundation of China(No.LS21H060001)the Alibaba Youth Studio Project(No.ZJU-032)the Zhejiang Province Medical and Health Science and Technology Program(Nos.2022KY1455 and 2022RC136).The funding bodies had no role in the design of the study,in collection,analysis,and interpretation of data,or in drafting the manuscript.We thank Fatima ALALIWI and Ma LING for their invaluable support and encouragement.
文摘Acral melanoma(AM)is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate,largely due to the inconspicuous nature of early-stage lesions,which can lead to late diagnosis.Because of the overlapping clinical and histopathological features of AM with other forms of cutaneous melanomas,early detection of AM requires a multidisciplinary approach that integrates various diagnostic modalities,including clinical examination,dermoscopy,histopathology,molecular testing,radiological imaging,and blood tests.While surgery is the preferred method of treatment for AM,other therapeutic options may be employed based on the stage and underlying etiology of the disease.Immune checkpoint inhibitors,molecular targeted therapy,radiotherapy,chemotherapy,and oncolytic virotherapy represent promising advanced treatment options for AM.In this review,we provide an overview of the latest advancements in diagnostic and therapeutic methods for AM,highlighting the importance of early detection and the prompt,individualized management of this challenging disease.
基金supported by the Medical Health Science and Technology Project of Zhejiang Provincial Health Com-mission(No.2022RC146)the Zhejiang Provincial Natural Science Foundation of China(No.LQ22H050003).
文摘Prostate cancer is the second most common cancer in men,accounting for 14.1%of new cancer cases in 2020.The aggressiveness of prostate cancer is highly variable,depending on its grade and stage at the time of diagnosis.Despite recent advances in prostate cancer treatment,some patients still experience recurrence or even progression after undergoing radical treatment.Accurate initial staging and monitoring for recurrence determine patient management,which in turn affect patient prognosis and survival.Classical imaging has limitations in the diagnosis and treatment of prostate cancer,but the use of novel molecular probes has improved the detection rate,specificity,and accuracy of prostate cancer detection.Molecular probe-based imaging modalities allow the visualization and quantitative measurement of biological processes at the molecular and cellular levels in living systems.An increased understanding of tumor biology of prostate cancer and the discovery of new tumor biomarkers have allowed the exploration of additional molecular probe targets.The development of novel ligands and advances in nano-based delivery technologies have accelerated the research and development of molecular probes.Here,we summarize the use of molecular probes in positron emission tomography(PET),single-photon emission computed tomography(SPECT),magnetic resonance imaging(MRI),optical imaging,and ultrasound imaging,and provide a brief overview of important target molecules in prostate cancer.
